Skip to main content
Premium Trial:

Request an Annual Quote

Quanterix, Sony DADC to Develop and Manufacture Consumables for SiMoA Platform

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quanterix and Sony DADC Austria today announced an agreement to develop and manufacture "smart consumables" for Quanterix's technology platform for the life sciences and in vitro diagnostic markets.

The companies are partnering on production of the Quanterix Single Molecule Array, or SiMoA, Discs, which would be the first diagnostic consumables with assay technology based on optical disc formats by Sony DADC, the two firms said.

Quanterix aims to develop and manufacture an automated instrument for its SiMoA technology, which will use the "smart consumables" to support a menu of diagnostic tests. The life science instrument and consumables are anticipated to reach the market in 2013. The company expects to commercialize an IVD platform in 2014.

"Partnering with Sony DADC on the SiMoA Disc is a major milestone toward our objective of delivering high-quality and cost-effective solutions to the clinical diagnostics and life science markets," Martin Madaus, executive chairman of Quanterix, said in a statement.

Earlier this year, the Cambridge, Mass.-based firm signed an agreement with Novartis for evaluation of the SiMoA platform for diagnostic purposes.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.